{"basic_info": {"ticker": "300347", "exchange": "XSHE", "bloomberg_ticker": "300347 CH Equity", "name": "HANGZHOU TIGERMED CONSULTI-A", "industry": "Life Sciences Tools & Services", "name_chinese_simplified": "泰格医药", "period": "2020", "market_value": 141423558656, "total_income": 3192278504, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 3176233863, "business_income_over_total_income": 0.9949739219244513}, {"shariah_compliance": "unknown", "income": 16044640, "business_income_over_total_income": 0.005026077762292885}], "details": [{"business_activity_cn": "临床试验技术服务", "business_activity_en": "Clinical Trials Technology Services", "income": 1519215298, "business_income_over_total_income": 0.47590311938522517, "shariah_compliance": "compliant"}, {"business_activity_cn": "临床试验相关服务", "business_activity_en": "Clinical Trials related services", "income": 1657018565, "business_income_over_total_income": 0.5190708025392261, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 16044640, "business_income_over_total_income": 0.005026077762292885, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.0035869292215078103, "shariah_compliance": "compliant", "amount_over_market_value": 0.0035869292215078103}]}